The University of Chicago Header Logo

Connection

Barbara Kirschner to Antibodies, Monoclonal

This is a "connection" page, showing publications Barbara Kirschner has written about Antibodies, Monoclonal.
Connection Strength

0.390
  1. Timing infliximab therapy in pediatric Crohn's disease. Gastroenterology. 2007 Mar; 132(3):1167-70.
    View in: PubMed
    Score: 0.179
  2. Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb; 146(2):383-91.
    View in: PubMed
    Score: 0.071
  3. Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab. J Pediatr Gastroenterol Nutr. 2012 Jan; 54(1):28-33.
    View in: PubMed
    Score: 0.063
  4. Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium. Inflamm Bowel Dis. 2005 May; 11(5):442-6.
    View in: PubMed
    Score: 0.039
  5. CDP571, a humanized anti-tumor necrosis factor-alpha monoclonal antibody in pediatric Crohn's disease. Inflamm Bowel Dis. 2004 Nov; 10(6):723-30.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.